logo
welcome
Reuters

Reuters

Pfizer to offload about 6% stake in Sensodyne-maker Haleon, says bookrunner

Reuters
Summary
Nutrition label

82% Informative

Pfizer intends to sell 540 million shares in British consumer healthcare company Haleon .

The top shareholder's interest in the Sensodyne maker to 16.2% .

Haleon separately said it had agreed to make an off-market purchase of about 230 million pounds ( $308.18 million ) Pfizer had sold about $3.5 billion worth stake in Haleon in March .

VR Score

92

Informative language

97

Neutral language

86

Article tone

formal

Language

English

Language complexity

48

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links